✦ LIBER ✦

157 Fecal Loss of Infliximab As a Cause of Lack of Response in Severe Inflammatory Bowel Disease

✍ Scribed by Brandse, Johannan F; Wildenberg, Manon; de Bruyn, Jessica R.; Wolbink, Gert-Jan; Lowenberg, M.; Ponsioen, Cyriel; van den Brink, Gijs R.; D'Haens, Geert R.

Book ID: 122261637
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 433 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)60128-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P500 Fecal loss of infliximab as a cause

P500 Fecal loss of infliximab as a cause of lack of response in severe inflammatory bowel disease

✍ Brandse, J.F.; Wildenberg, M.E.; de Bruyn, J.R.; Wolbink, G.; Lowenberg, M.; Pon 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 55 KB

Back to the Beginning: Restarting Inflix

Back to the Beginning: Restarting Infliximab in Inflammatory Bowel Disease Patients With Prior Loss of Response

✍ Yarur, Andres J.; Abreu, Maria T. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P222 Fecal calprotectin as a marker of s

P222 Fecal calprotectin as a marker of severity of mucosal involvement in children with inflammatory bowel disease

✍ Dolinsek, J.; Riznik, P.; Sabath, L.; Micetic-Turk, D. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Role of fecal calprotectin as a biomarke

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

✍ Michael R. Konikoff; Lee A. Denson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Sa1257 Persistence of Antibodies to Infl

Sa1257 Persistence of Antibodies to Infliximab for More Than Two Months Predicts Loss of Response to Infliximab in Inflammatory Bowel Diseases

✍ Leclerc, Manon; Marotte, Hubert; Paul, Stephane; Del Tedesco, Emilie; Phelip, Je 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 231 KB

P387 Persistence of antibodies to inflix

P387 Persistence of antibodies to infliximab for more than two months strongly predicts loss of response to infliximab in inflammatory bowel diseases

✍ Leclerc, M.; Marotte, H.; Paul, S.; Del Tedesco, E.; Gonzalo, P.; Phelip, J.M.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 66 KB